List of Tables
Table 1. Global Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Class
Table 3. Key Players of Minimally Invasive Surgeries
Table 4. Key Players of Laser Therapy
Table 5. Key Players of Others
Table 6. Global Benign Prostatic Hyperplasia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Benign Prostatic Hyperplasia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Benign Prostatic Hyperplasia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia Treatment Market Share by Region (2020-2025)
Table 10. Global Benign Prostatic Hyperplasia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Benign Prostatic Hyperplasia Treatment Market Share by Region (2026-2031)
Table 12. Benign Prostatic Hyperplasia Treatment Market Trends
Table 13. Benign Prostatic Hyperplasia Treatment Market Drivers
Table 14. Benign Prostatic Hyperplasia Treatment Market Challenges
Table 15. Benign Prostatic Hyperplasia Treatment Market Restraints
Table 16. Global Benign Prostatic Hyperplasia Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Benign Prostatic Hyperplasia Treatment Market Share by Players (2020-2025)
Table 18. Global Top Benign Prostatic Hyperplasia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Treatment as of 2024)
Table 19. Ranking of Global Top Benign Prostatic Hyperplasia Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Benign Prostatic Hyperplasia Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Benign Prostatic Hyperplasia Treatment, Headquarters and Area Served
Table 22. Global Key Players of Benign Prostatic Hyperplasia Treatment, Product and Application
Table 23. Global Key Players of Benign Prostatic Hyperplasia Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Benign Prostatic Hyperplasia Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Benign Prostatic Hyperplasia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Benign Prostatic Hyperplasia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Benign Prostatic Hyperplasia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Benign Prostatic Hyperplasia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Benign Prostatic Hyperplasia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Benign Prostatic Hyperplasia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Benign Prostatic Hyperplasia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Benign Prostatic Hyperplasia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott Benign Prostatic Hyperplasia Treatment Product
Table 51. Abbott Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Allergan plc Company Details
Table 54. Allergan plc Business Overview
Table 55. Allergan plc Benign Prostatic Hyperplasia Treatment Product
Table 56. Allergan plc Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 57. Allergan plc Recent Development
Table 58. Astellas Pharma Company Details
Table 59. Astellas Pharma Business Overview
Table 60. Astellas Pharma Benign Prostatic Hyperplasia Treatment Product
Table 61. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 62. Astellas Pharma Recent Development
Table 63. Asahi Kasei Corporation Company Details
Table 64. Asahi Kasei Corporation Business Overview
Table 65. Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Product
Table 66. Asahi Kasei Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 67. Asahi Kasei Corporation Recent Development
Table 68. Boehringer Ingelheim GmbH Company Details
Table 69. Boehringer Ingelheim GmbH Business Overview
Table 70. Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Product
Table 71. Boehringer Ingelheim GmbH Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 72. Boehringer Ingelheim GmbH Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Product
Table 76. GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Pfizer Company Details
Table 79. Pfizer Business Overview
Table 80. Pfizer Benign Prostatic Hyperplasia Treatment Product
Table 81. Pfizer Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Benign Prostatic Hyperplasia Treatment Product
Table 86. Sanofi Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Teva Pharmaceutical Industries Company Details
Table 89. Teva Pharmaceutical Industries Business Overview
Table 90. Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Product
Table 91. Teva Pharmaceutical Industries Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 92. Teva Pharmaceutical Industries Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Benign Prostatic Hyperplasia Treatment Product
Table 96. Merck Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 97. Merck Recent Development
Table 98. Boston Scientific Corporation Company Details
Table 99. Boston Scientific Corporation Business Overview
Table 100. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Product
Table 101. Boston Scientific Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 102. Boston Scientific Corporation Recent Development
Table 103. Teleflex Incorporated Company Details
Table 104. Teleflex Incorporated Business Overview
Table 105. Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Product
Table 106. Teleflex Incorporated Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 107. Teleflex Incorporated Recent Development
Table 108. Endo International Company Details
Table 109. Endo International Business Overview
Table 110. Endo International Benign Prostatic Hyperplasia Treatment Product
Table 111. Endo International Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 112. Endo International Recent Development
Table 113. Urologix Company Details
Table 114. Urologix Business Overview
Table 115. Urologix Benign Prostatic Hyperplasia Treatment Product
Table 116. Urologix Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 117. Urologix Recent Development
Table 118. LISA Laser Company Details
Table 119. LISA Laser Business Overview
Table 120. LISA Laser Benign Prostatic Hyperplasia Treatment Product
Table 121. LISA Laser Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 122. LISA Laser Recent Development
Table 123. Olympus Company Details
Table 124. Olympus Business Overview
Table 125. Olympus Benign Prostatic Hyperplasia Treatment Product
Table 126. Olympus Revenue in Benign Prostatic Hyperplasia Treatment Business (2020-2025) & (US$ Million)
Table 127. Olympus Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Benign Prostatic Hyperplasia Treatment Picture
Figure 2. Global Benign Prostatic Hyperplasia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Benign Prostatic Hyperplasia Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drug Class Features
Figure 5. Minimally Invasive Surgeries Features
Figure 6. Laser Therapy Features
Figure 7. Others Features
Figure 8. Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Benign Prostatic Hyperplasia Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Benign Prostatic Hyperplasia Treatment Report Years Considered
Figure 15. Global Benign Prostatic Hyperplasia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Benign Prostatic Hyperplasia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Benign Prostatic Hyperplasia Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Benign Prostatic Hyperplasia Treatment Market Share by Players in 2024
Figure 19. Global Top Benign Prostatic Hyperplasia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Benign Prostatic Hyperplasia Treatment Revenue in 2024
Figure 21. North America Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Benign Prostatic Hyperplasia Treatment Market Share by Country (2020-2031)
Figure 23. United States Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Benign Prostatic Hyperplasia Treatment Market Share by Country (2020-2031)
Figure 27. Germany Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Share by Region (2020-2031)
Figure 35. China Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Benign Prostatic Hyperplasia Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Benign Prostatic Hyperplasia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Abbott Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 51. Allergan plc Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 52. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 53. Asahi Kasei Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 54. Boehringer Ingelheim GmbH Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 56. Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 57. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 59. Merck Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 60. Boston Scientific Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 61. Teleflex Incorporated Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 62. Endo International Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 63. Urologix Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 64. LISA Laser Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 65. Olympus Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
